Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program
ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a second trailer to its nationwide mobile lab training program making it even more convenient for the company to facilitate on-site surgeon training and education. Paragon 28’s new mobile lab is housed in a 40 foot tractor-trailer which includes a state-of-the-art, 5 station, cadaveric training facility accommodating up to 25 surgeons. The mobile lab will host over 70 training sessions in approximately 65 US cities during quarter four of 2023. The mobile lab program kicked off in July of 2022 and has been an incredible success for Paragon 28, allowing the company to efficiently train over 350 surgeons.
“We are very excited to add a second lab to our mobile education program and increase our ability to bring education directly to surgeons. The mobile lab program has allowed Paragon 28 to find the most effective venue for medical education to support our growing product portfolio and surgeon customers,” said Albert DaCosta, CEO and Co-Founder of Paragon 28. “The mobile lab program has proven to be a versatile option to showcase P28’s broad and innovative product portfolio which includes new solutions in the growing forefoot, HAV, and hindfoot market segments.”
To learn more about the Paragon 28 Surgeon Mobile Lab, please visit the following site: Paragon 28 Mobile Lab
About Paragon 28, Inc.
Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.
